Subclinical Hypothyroidism Diagnosis and Characteristics

Definition and Prevalence

Subclinical hypothyroidism is defined as an elevated thyroid stimulating hormone (TSH) level above the normal reference range with normal free thyroxine (FT4) and triiodothyronine (T3) levels, according to the American Medical Association 1
Subclinical hypothyroidism affects approximately 4-8.5% of the general population without known thyroid disease, with higher prevalence in women, especially those over 60 years old, where it can reach up to 20% 2
The normal reference range for TSH is considered to be 0.45-4.5 mIU/L, as stated by the American Medical Association 1, 2

Age, female gender, family history of thyroid disease, previous hyperthyroidism, type 1 diabetes mellitus, previous head and neck radiation treatment, and presence of antithyroid antibodies are risk factors for subclinical hypothyroidism, as identified by the American Medical Association 2
Approximately 2-5% of patients with subclinical hypothyroidism progress to overt hypothyroidism each year, with higher risk of progression associated with higher baseline TSH levels and presence of antithyroid antibodies 2

Subclinical hypothyroidism may be associated with cardiac dysfunction and possible increased risk of cardiovascular events, as well as elevated total and LDL cholesterol levels, according to the American Heart Association 3
Patients with subclinical hypothyroidism may experience systemic hypothyroid symptoms, neuropsychiatric symptoms, and increased risk of progression to overt hypothyroidism 2, 3

Other conditions can cause temporary TSH elevation and should be excluded, including recent adjustments in levothyroxine dosage, recovery from severe illness, recovery from thyroiditis, untreated adrenal insufficiency, and laboratory interference from heterophilic antibodies, as noted by the American Medical Association 1
TSH values can be affected by medications like dopamine, glucocorticoids, and dobutamine, according to the American Medical Association 4